Iproniazid
(Preusmjereno sa stranice Ipronijazid)
Iproniazid (Eufozid, Iprazid, Ipronid, Ipronin, Marsilid, Rivivol) je hidrazinski lek koji je korišten kao antidepresiv.[6] On deluje kao ireverzibilni i neselektivni inhibitor monoaminske oksidaze (MAOI).[7]
(IUPAC) ime | |||
---|---|---|---|
N'-izopropilizonikotinohidrazid | |||
Klinički podaci | |||
AHFS/Drugs.com | Internacionalno ime leka | ||
Identifikatori | |||
CAS broj | 54-92-2 | ||
ATC kod | N06AF05 | ||
PubChem[1][2] | 3748 | ||
DrugBank | DB04818 | ||
ChemSpider[3] | 3617 | ||
UNII | D892HFI3XA | ||
KEGG[4] | D02579 | ||
ChEMBL[5] | CHEMBL92401 | ||
Hemijski podaci | |||
Formula | C9H13N3O | ||
Mol. masa | 179,219 | ||
SMILES | eMolekuli & PubHem | ||
| |||
Farmakokinetički podaci | |||
Bioraspoloživost | ? | ||
Metabolizam | ? | ||
Poluvreme eliminacije | ? | ||
Izlučivanje | ? | ||
Farmakoinformacioni podaci | |||
Trudnoća | ? | ||
Pravni status | ? | ||
Način primene | ? |
Reference uredi
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.
- ↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
- ↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.
- ↑ Robert A. Maxwell, Shohreh B. Eckhardt (1990). Drug discovery. Humana Press. str. 143–154. ISBN 9780896031807.
- ↑ Fagervall I, Ross SB (April 1986). „Inhibition of monoamine oxidase in monoaminergic neurones in the rat brain by irreversible inhibitors”. Biochemical pharmacology 35 (8): 1381–7. DOI:10.1016/0006-2952(86)90285-6. PMID 2870717.